Pages that link to "Q43964066"
Jump to navigation
Jump to search
The following pages link to Obligatory role of membrane events in the regulatory effect of metformin on the respiratory chain function (Q43964066):
Displaying 41 items.
- Cellular and molecular mechanisms of metformin: an overview (Q27013561) (← links)
- Niclosamide reduces glucagon sensitivity via hepatic PKA inhibition in obese mice: Implications for glucose metabolism improvements in type 2 diabetes (Q28359714) (← links)
- Metformin reduces hepatic expression of SIRT3, the mitochondrial deacetylase controlling energy metabolism (Q28485245) (← links)
- Metformin impairs mitochondrial function in skeletal muscle of both lean and diabetic rats in a dose-dependent manner (Q28539904) (← links)
- Metformin and respiratory chain complex I: the last piece of the puzzle? (Q33359251) (← links)
- Impact of metformin on reproductive tissues: an overview from gametogenesis to gestation (Q34357928) (← links)
- Pharmacologic Means of Extending Lifespan. (Q34449372) (← links)
- Metformin--mode of action and clinical implications for diabetes and cancer (Q34658712) (← links)
- Metformin-clinical pharmacology in PCOs (Q35349627) (← links)
- Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status (Q35534198) (← links)
- Mitochondrial metabolism and type-2 diabetes: a specific target of metformin (Q35539967) (← links)
- Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue (Q35737581) (← links)
- Structurally diverse c-Myc inhibitors share a common mechanism of action involving ATP depletion (Q36140644) (← links)
- Metformin revisited: re-evaluation of its properties and role in the pharmacopoeia of modern antidiabetic agents (Q36283811) (← links)
- Metformin overdose causes platelet mitochondrial dysfunction in humans. (Q36928172) (← links)
- Peroxisome Proliferator-Activated Receptor-gamma in Amyotrophic Lateral Sclerosis and Huntington's Disease (Q37157528) (← links)
- The Role of Metformin in Controlling Oxidative Stress in Muscle of Diabetic Rats (Q37184638) (← links)
- Blood content of asymmetric dimethylarginine: new insights into its dysregulation in renal disease (Q37324434) (← links)
- Natural products for type II diabetes treatment (Q37727562) (← links)
- The ADMA-Metformin Hypothesis: Linking the Cardiovascular Consequences of the Metabolic Syndrome and Type 2 Diabetes (Q37963876) (← links)
- Targeting metabolism for cancer treatment and prevention: metformin, an old drug with multi-faceted effects (Q38016107) (← links)
- New molecules and old drugs as emerging approaches to selectively target human glioblastoma cancer stem cells (Q38187997) (← links)
- Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells. (Q38811683) (← links)
- Metformin-associated lactic acidosis (MALA): Moving towards a new paradigm. (Q39247550) (← links)
- New insights into antidiabetic drugs: Possible applications in cancer treatment. (Q39272833) (← links)
- Effect of the AMP-kinase modulators AICAR, metformin and compound C on insulin secretion of INS-1E rat insulinoma cells under standard cell culture conditions. (Q39380440) (← links)
- Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study (Q40549699) (← links)
- Biological and biophysics aspects of metformin-induced effects: cortex mitochondrial dysfunction and promotion of toxic amyloid pre-fibrillar aggregates. (Q41152081) (← links)
- Imeglimin prevents human endothelial cell death by inhibiting mitochondrial permeability transition without inhibiting mitochondrial respiration (Q41977926) (← links)
- Metformin promotes isolated rat liver mitochondria impairment. (Q46971446) (← links)
- Exon 3 mutations of CTNNB1 drive tumorigenesis: a review (Q49427525) (← links)
- Differential associations of circulating asymmetric dimethylarginine and cell adhesion molecules with metformin use in patients with type 2 diabetes mellitus and stable coronary artery disease. (Q53548426) (← links)
- Metformin exerts antitumor activity via induction of multiple death pathways in tumor cells and activation of a protective immune response. (Q55262517) (← links)
- Metformin reduces asymmetric dimethylarginine and prevents hypertension in spontaneously hypertensive rats (Q57845342) (← links)
- Analyses of Biguanides and Related Compounds in Biological and Environmental Samples by HPLC (Q59150041) (← links)
- Metformin in Reproductive Biology (Q59812969) (← links)
- Metformin-Induced Mitochondrial Complex I Inhibition: Facts, Uncertainties, and Consequences (Q60951015) (← links)
- Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity (Q64098059) (← links)
- Role of Mitochondria in the Mechanism(s) of Action of Metformin (Q64248506) (← links)
- p21cip1/waf1 Coordinate Autophagy, Proliferation and Apoptosis in Response to Metabolic Stress (Q92422648) (← links)
- Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus (Q92797743) (← links)